Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 36,185 shares of RCKT stock, worth $144,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,185
Previous 21,885
65.34%
Holding current value
$144,740
Previous $145,000
39.31%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RCKT
# of Institutions
219Shares Held
98.7MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$70.8 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$33.5 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$24.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$24.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$19.3 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $303M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...